HIV (Human Immunodeficiency Virus) / AIDS (Acquired Immune Deficiency Syndrome)
HIV/AIDS is contracted when an HIV-positive person passes the virus to another person through blood, vaginal fluid, semen, or breast milk. While HIV can't kill someone, oftentimes people with HIV are vulnerable to opportunistic infections that can damage the immune system and lead to the development of AIDS. Unfortunately, there is no known cure for AIDS, and for many who are diagnosed with HIV/AIDS, they feel they are being handed a death sentence. It's no wonder considering the following disturbing facts:
|
|
|
When HIV/AIDS patients answered a recent survey on day-to-day concerns, over
half stated that personal finances are the number one problem facing them
today. Families and loved ones of AIDS patients oftentimes have to take the
burden of medical expenses. Savings and other investments that were meant
for retirement get spent on the treatment for AIDS. These mounting health
care costs that range from doctor visits to home health care may or may not
be covered by your health plan. Quality of life shouldn't be a financial
factor!
Asset Funding Corp. can relieve your financial hardship by providing
funds for medical care, mortgages and living expenses. After all,
Viatical Settlements are about living, not dying. Money obtained from
Viatical Settlements can be very useful when you consider how expensive
treatments are.
Why spend the last moments of life fighting bankruptcy? Your Viatical
Settlement pays cash now and relieves the financial burden from you and your
loved ones.
Asset Funding Corp. turns that
death benefit on your life insurance policy into living benefits so that you
can enjoy your life. Let Asset Funding Corp. help you today!
Call 1-800-542-9513 or email
us today for more information on how to turn your life
insurance policy into cash!
*(Kochanek, K.D. et al, Deaths: Preliminary data for 1999. National Vital
Statistics Reports; vol. 49, no. 3. Hyattsville, Maryland: National Center
for Health Statistics, 2001.)
**(Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance
Report 2000;12(no.2):1-44)
***(Drug Topics Red Book. Montvale, NJ: Medical Economics; 1996.)

